1.
A Frequency Analysis of Blood Sugar Declining Through 6-year Medicine-taking Process in Fengcheng People Hospital;
某综合性医院口服降血糖药物6年使用频度分析
2.
Analysis of Oral Hypoglycemic Drugs Used in Our Hospital
我院2006～2008年口服降糖药物应用分析
3.
Analysis of Utilization of Oral Hypoglycemic Drugs in Our Hospital from 2006 to 2008
2006-2008年我院口服降糖药物的应用分析
4.
Effect of Different Oral Hypoglycemic Agents on Glycaemic Control and Pancreatic β Cell Function in Type 2 Diabetes
不同口服降糖药物对2型糖尿病患者血糖及胰岛β细胞功能的影响
5.
Analysis on Pharmaceutical Economics of Different Oral Antidiabetic Drugs for Treating Type-2 Diabetes Mellitus
5种口服降糖药治疗2型糖尿病的药物经济学分析
6.
Metformin and a generic sulfonylurea should be the basis of oral glucose lowering therapy.
二甲双胍和一般磺脲类药物时口服降糖药物的治疗基础。
7.
Analysis of Use of Oral Antidiabetic Drugs in Elderly Diabetic Patients
本院老年糖尿病患者口服降糖药分析
8.
Analysis on use of oral hypoglycemic drugs in a hospital from 2006 to 2008
2006～2008年我院口服降糖药的应用分析
9.
Utilization of Oral Hypoglycemic Agents in Our Hospital in 2008
2008年我院口服降糖药应用分析
10.
Utilization of the Oral Antidiabetic Drugs During 2004～2007 in Our Hospital
2004～2007年我院口服降糖药应用分析
11.
Utilization of Oral Antidiabetic Drugs in Outpatients of Our Hospital During the Period 2006～2008
2006～2008年我院门诊口服降糖药应用分析
12.
Utilization of Oral Hypoglycemic Drugs in Nanjing During the Period 2006～2008
2006～2008年南京地区口服降糖药应用分析
13.
Utilization of Oral Hypoglycemic Drugs in Our Hospital During the Period 2006～2008
2006～2008年我院口服降糖药应用分析
14.
Analysis of Oral Hypoglycemic Drugs Used in Our Hospital during Period 2005-2007
我院2005—2007年口服降糖药应用情况分析
15.
The Abilities and Associated Hypoglycemia Risks of Oral Therapy Added to Insulin Glargine or Human NPH Insulin in the Patients with T2DM
2型糖尿病患者口服降糖药控制不佳时配伍相关药物的疗效与安全性
16.
Brand name Amaryl; an oral medicine used to treat type 2 diabetes.
商品名：亚莫利,为治疗2型糖尿病的口服降糖药。
17.
The cost-effectiveness analyze of oral hypoglycemic drugs in the treatment of type2 diabetes mellitus
2型糖尿病患者口服降糖药的成本-效果分析
18.
Cost-effectiveness analysis of drugs in treatment of type 2 diabetes mellitus
2型糖尿病患者口服降糖药的成本效果分析